ACTRIMS/ECTRIMS 2020: Anti-CD20 Therapy Associated With Greater COVID-19 Disease Severity in Patients With Multiple Sclerosis
Relationships with poorer outcomes were strongest for rituximab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.